Background: Chorioangiomas are the most common placental tumours with a prevalence of approximately 1%, among placentas that have undergone histological examination(1). Chorioangiomas are often small, undetected and of little clinical significance. However, large chorioangiomas (>4 cm), while less common, are more likely to be diagnosed perinatally and are associated with a range of adverse perinatal outcomes as well as a significantly increased foetal mortality rate of 30-40%(2).
Method:
We describe a case of a large chorioangioma and discuss the ultrasound features, and antenatal counselling in this clinical situation.
Results: A 37-year-old multiparous was referred at 30 + 5 weeks' gestation with the antenatal diagnosis of a chorioangioma (6.9cmx4.9cmx3cm). The patient was managed expectantly with regular antenatal care, ultrasound assessment, and CTG monitoring. The parents were counselled regarding the risks of polyhydramnios, pre-eclampsia, preterm delivery, fetomaternal haemorrhage, fetal growth restriction, congestive cardiac failure, fetal anaemia, hydrops, and fetal death. This condition and the plan for the pregnancy was discussed in detail.
Conclusion: Given the high risk of poor perinatal outcomes associated with chorioangioma; extensive antenatal counselling, surveillance, appropriate treatment, and timely delivery are recommended to prevent potential complications and mortality, regardless of the presence of complications at the time of diagnosis.
References: The safety and feasibility of outpatient care for infants affected by drug-use disorders, especially those requiring medication for Neonatal Abstinence Syndrome (NAS), is unclear.
Method: Retrospective chart review of 774 inborn motherinfant dyads managed as outpatients by the Chemical Use in Pregnancy Service (CUPS) at Randwick, NSW, Australia between 1998-2016. The study period was divided into 2 epochs, based on the National NAS Guidelines first published in 2006: epoch 1, 1998-2006, n = 404 and epoch 2, 2007-2016, n = 370 .
Results: Attendance rate in the clinic was greater than 90%. In epoch 2, opioid use decreased (OR 0.4) and amphetamine use increased (OR 1.8). Mothers received antenatal care earlier (16 vs 19 weeks) and infants were more mature (37.9 vs 37.6 weeks) and heavier (2937 v 2832 grams). Fewer children were involved with child protection services (OR 0.7) but reports were more often made prenatally (OR 7.4). Hospitalisation was shorter (9 vs 7.5 days) and fewer opioid-exposed babies were medicated for NAS (OR 0.3). In total, 199 infants were discharged on withdrawal medication. Three medication errors occurred -none with permanent sequelae. Five children died (SIDS = 4, drowning = 1), aged between 2.2-15 months. No infants were concurrently medicated or still attending the clinic at the time of death.
